Article

PAREXEL Enhances Data-Driven Monitoring

 

PAREXEL has added risk-based monitoring capabilities, expanding its Perceptive MyTrials®  Data-Driven Monitoring (DDM) solution.  Data-Driven Monitoring now further enables clients to perform cross-study analysis of quality, risk, and monitoring work effort by combining analytics, reporting and monitoring activity into a single cohesive solution.  The enhancements increase the ability to demonstrate appropriate oversight and control of site-related risk, quality, and performance while simplifying monitoring governance and execution.

Read the full release

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.